“Incorporating the 40-Gene Expression Profile (40-GEP) Test Within Each Clinicopathologic Staging System Improves Metastatic Risk-Stratification in Patients Diagnosed With Cutaneous Squamous Cell Carcinoma (cSCC) and One or More High Risk Factors”. 2024. SKIN The Journal of Cutaneous Medicine 8 (1): s334. https://doi.org/10.25251/skin.8.supp.334.